-
Product Insights
Skin And Skin Structure Infections (SSSI) Caused By Bacteria - Drugs In Development, 2024
Empower your strategies with our Skin And Skin Structure Infections (SSSI) Caused By Bacteria – Drugs In Development, 2024 report and make more profitable business decisions. Skin and Skin Structure Infections (SSSIs) caused by bacteria encompass a spectrum of infections affecting the skin and underlying tissues, varying from mild to severe and instigated by diverse bacteria. Notable culprits include Staphylococcus aureus, including methicillin-resistant strains (MRSA), Streptococcus pyogenes (group A Streptococcus), and other streptococcal species. SSSI can manifest as cellulitis, erysipelas, impetigo,...
-
Product Insights
Yellow Fever - Drugs In Development, 2024
Empower your strategies with our Yellow Fever – Drugs In Development, 2024 report and make more profitable business decisions. Yellow fever is an acute systemic illness (hemorrhagic fever) caused by a flavivirus. It is spread by mosquitoes. Symptoms include irregular heartbeat, bleeding, vomiting, coma, delirium, fever, headache, and muscle aches. There is no specific treatment for yellow fever, so patients are treated to relieve the symptoms. The Yellow Fever drugs in development market research report provide comprehensive information on the therapeutics...
-
Product Insights
Haemophilus influenzae Type B Infections - Drugs In Development, 2024
Empower your strategies with our Haemophilus influenzae Type B Infections – Drugs In Development, 2024 report and make more profitable business decisions. Haemophilus influenzae type B (Hib) is a bacterium that causes an infection that can lead to serious or life-threatening illness, especially in children. Symptoms include severe headache, stiff neck, convulsions or seizures, severe drowsiness, difficulty waking up, loss of consciousness, or difficulty breathing. Predisposing factors include age and weakened immune system. Treatment includes antibiotics. The Haemophilus influenzae Type B...
-
Product Insights
Helicobacter pylori Infections - Drugs In Development, 2024
Empower your strategies with our Helicobacter pylori Infections – Drugs In Development, 2024 report and make more profitable business decisions. Helicobacter pylori (H. pylori) infection occurs when the Helicobacter pylori (H. pylori) bacteria infect the stomach, typically during childhood. A leading cause of stomach ulcers, this infection is asymptomatic for many, with over half of the global population potentially affected. Recognition often arises when peptic ulcer symptoms manifest, prompting healthcare providers to test for H. pylori. Peptic ulcers, affecting the stomach...
-
Product Insights
Hepatitis D - Drugs In Development, 2024
Empower your strategies with our Hepatitis D – Drugs In Development, 2024 report and make more profitable business decisions. Hepatitis D, also known as the delta virus, is an infection that causes the liver to swell. It is caused by the hepatitis D virus (HDV). Symptoms include yellowing of skin and eyes, joint pain, abdominal pains, vomiting, loss of appetite, and fatigue. Risk factors include receiving many blood transfusions, abusing intravenous (IV) or injection drugs, and being infected while pregnant. The...
-
Product Insights
Lassa Fever (Lassa Hemorrhagic Fever) - Drugs In Development, 2024
Empower your strategies with our Lassa Fever (Lassa Hemorrhagic Fever) – Drugs In Development, 2024 report and make more profitable business decisions. Lassa fever is an acute viral hemorrhagic illness caused by Lassa virus, a member of the arenavirus family of viruses. It is transmitted to humans from contacts with food or household items contaminated with rodent excreta. Symptoms include fever, headache, chills, back pain, weight loss, swollen neck, rashes, and bleeding. The antiviral drug ribavirin seems to be an effective...
-
Product Insights
Lyme Disease - Drugs In Development, 2024
Empower your strategies with our Lyme Disease – Drugs In Development, 2024 report and make more profitable business decisions. Lyme disease is a bacterial infection transmitted by a tick. Lyme disease is caused by the bacterium Borrelia burgdorferi. Symptoms include rash, fever, chills, fatigue, body aches, and headache. Risk factors include age, gender, and geographic location. Treatment includes antibiotics. The Lyme Disease drugs in development market research report provide comprehensive information on the therapeutics under development for Lyme Disease, complete with...
-
Product Insights
Neisseria gonorrhoeae Infections - Drugs In Development, 2024
Empower your strategies with our Neisseria gonorrhoeae Infections – Drugs In Development, 2024 report and make more profitable business decisions. Neisseria gonorrhoeae, the bacterium accountable for the sexually transmitted infection (STI) gonorrhea, is a notable public health issue causing substantial global morbidity in both resource-rich and resource-poor nations. The diagnosis and treatment of this infection entail considerable financial expenditures each year. Similar to other sexually transmitted infections (STIs), gonorrhea has a disproportionate impact on young adults. The obligate human pathogen N....
-
Product Insights
Pandemic Influenza - Drugs In Development, 2024
Empower your strategies with our Pandemic Influenza – Drugs In Development, 2024 report and make more profitable business decisions. A flu pandemic is characterized by the worldwide spread of a novel flu A virus, and it occurs when this emerging virus has the capability to efficiently infect and transmit among humans, affecting a large population with limited immunity. Such pandemics are marked by the ability of the new influenza A virus to spread easily from person to person. The most recent...
-
Product Insights
Systemic Candidiasis - Drugs In Development, 2024
Empower your strategies with our Systemic Candidiasis – Drugs In Development, 2024 report and make more profitable business decisions. Systemic candidiasis encompasses a range of yeast infections resulting from various species of Candida, presenting a severe threat that can impact diverse areas of the body such as the blood, heart, brain, eyes, bones, and other organs. While there are over 200 Candida species, five specific types contribute to 90% of systemic candidiasis cases. The primary manifestation of this invasive yeast infection...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.